Amedisys Inc (AMED) News

Amedisys Inc (AMED): $95.49

0.89 (+0.94%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add AMED to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#7 of 62

in industry

Filter AMED News Items

AMED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest AMED News From Around the Web

Below are the latest news stories about AMEDISYS INC that investors may wish to consider to help them evaluate AMED as an investment opportunity.

20 Most Medically Advanced Countries in the World Heading into 2024

In this article, we’ll take a look at the 20 Most Medically Advanced Countries in the World Heading into 2024. We’ll also deep diver into the medical industry market insights and some key players in the industry. To skip the detailed analysis and see the top 5 countries, read 5 Most Medically Advanced Countries in […]

Yahoo | November 30, 2023

Chemed (CHE) Up 4.8% Since Last Earnings Report: Can It Continue?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | November 24, 2023

Amedisys (AMED) Up 2.6% Since Last Earnings Report: Can It Continue?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | November 23, 2023

3 Stocks Profiting from America’s Long-Term Care Crisis

These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement.

Will Ashworth on InvestorPlace | November 22, 2023

Amedisys' (AMED) Q3 Earnings Miss Estimates, Margins Up

The continuous shortage of clinical labor, nursing in particular, is likely to have impacted Amedisys' (AMED) Q3 performance.

Yahoo | October 26, 2023

Q3 2023 Option Care Health Inc Earnings Call

Q3 2023 Option Care Health Inc Earnings Call

Yahoo | October 26, 2023

Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Yahoo | October 24, 2023

Amedisys Inc (AMED) Reports Q3 2023 Earnings: Net Income Rises Despite Decrease in Net Service ...

Company's net income increases while net service revenue shows a slight decrease compared to Q3 2022

Yahoo | October 24, 2023

Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates

Amedisys (AMED) delivered earnings and revenue surprises of -9.26% and 0.99%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | October 24, 2023

Amedisys Reports Third Quarter 2023 Financial Results

BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023. Three-Month Periods Ended September 30, 2023 and 2022 Net service revenue decreased $1.8 million to $556.2 million compared to $558.0 million in 2022. Prior year included $16.6 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc.

Yahoo | October 24, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!